ArticleBMC cancer2021

Investigating efficacy of "microbiota modulation of the gut-lung Axis" combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial.

Qing Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.